Drugmakers may only be scratching the surface of mRNA, the platform Pfizer and Moderna used to develop the first two COVID-19 vaccines granted emergency use authorization by the FDA.
COVID-19 vaccines that use mRNA provide instructions for a cell to make a protein, inciting an immune response to enhance the body’s ability to fight the actual virus, according to Indu Lew, PharmD, the chief pharmacy officer at West Orange, N.J.-based RWJBarnabas Health.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,